Why the study?
Elevated adipocyte E2F1 expression in human visceral adipose tissue associates with poor cardiometabolic profile, but whether E2F1 governs a distinct transcriptome contributing to adipose tissue and metabolic dysfunction was unknown.
An intra-adipose tissue E2F1-associated TNFSF paracrine loop involving TRAIL and TL1A contributes to adipose tissue dysfunction and metabolic complications in human obesity.
Answers are grounded in this paper and cite their sources.
E2F1 in visceral adipocytes may mark cardiometabolic risk in obesity; leaves open causal role and therapeutic targeting.
Elevated expression of E2F1 in adipocyte fraction of human visceral adipose tissue (hVAT) associates with a poor cardiometabolic profile. We hypothesized that beyond directly activating autophagy and MAP3K5 (ASK)–MAP kinase signaling, E2F1 governs a distinct transcriptome that contributes to adipose tissue and metabolic dysfunction in obesity. We performed RNA sequencing of hVAT samples from age-, sex-, and BMI-matched patients, all obese, whose visceral E2F1 protein expression was either high (E2F1high) or low (E2F1low). Tumor necrosis factor superfamily (TNFSF) members, including TRAIL (TNFSF10), TL1A (TNFSF15), and their receptors, were enriched in E2F1high. While TRAIL was equally expressed in adipocytes and stromal vascular fraction (SVF), TL1A was mainly expressed in SVF, and TRAIL-induced TL1A was attributed to CD4+ and CD8+ subclasses of hVAT T cells. In human adipocytes, TL1A enhanced basal and impaired insulin-inhibitable lipolysis and altered adipokine secretion, and in human macrophages it induced foam cell biogenesis and M1 polarization. Two independent human cohorts confirmed associations between TL1A and TRAIL expression in hVAT and higher leptin and IL6 serum concentrations, diabetes status, and hVAT-macrophage lipid content. Jointly, we propose an intra-adipose tissue E2F1-associated TNFSF paracrine loop engaging lymphocytes, macrophages, and adipocytes, ultimately contributing to adipose tissue dysfunction in obesity.
No takes yet. Share an insight, caveat, or question.
Maixner et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: